Fig. 6From: Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinomaNRPa-308 binding mode is different between NRP1 and NRP2. NRPa-308 (colored in orange) predicted binding mode into the NRP1 (a and b in cyan, left panels) and NRP2 (a and b in blue, right panels) binding sites. Hydrogen bonds are depicted as yellow dashed lines and π-stacking are depicted as magenta dashed linesBack to article page